SEC Tracker
Get the app

Rocket Pharmaceuticals RCKT

Gaurav Shah (Officer) plans to sell 20,272 RCKT shares, about $604,874

Form
144/A
Filed
Importance
Routine
Document
Form 144/A
  1. Approximate sale date: Feb 16, 2024
  2. Broker: Fidelity Brokerage Services LLC
  3. Shares acquired by: Restricted Stock Vesting

All of Gaurav Shah's insider filings, holdings and planned sales

Written from the Form 144/A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Rocket Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Perspective Therapeutics CATX public float $213M, Jun 30, 2025
  2. Natures Sunshine Products NATR public float $211M, Jun 30, 2025
  3. Tvardi Therapeutics TVRD public float $207M, Jun 30, 2025
  4. Silence Therapeutics SLN public float $206M, Jun 30, 2025
  5. SELLAS Life Sciences Group SLS public float $219M, Jun 30, 2025